Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Within Myford North FacilityGlobeNewsWire • 01/10/22
Follow The Leader: 3 Biopharma Stocks Displaying Relative StrengthZacks Investment Research • 12/29/21
Avid Bioservices (CDMO) Loses 24.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 12/15/21
Avid Bioservices, Inc.'s (CDMO) CEO Nick Green on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 12/07/21
Avid Bioservices (CDMO) Earnings Expected to Grow: What to Know Ahead of Q2 ReleaseZacks Investment Research • 11/24/21
Avid Bioservices Announces Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene TherapyGlobeNewsWire • 10/14/21
Down 20.1% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a TurnaroundZacks Investment Research • 09/14/21
Avid Bioservices, Inc. (CDMO) CEO Nick Green on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 09/09/21
Avid Bioservices, Inc. (CDMO) CEO Nick Green on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 06/30/21
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent DevelopmentsGlobeNewsWire • 06/29/21
Avid Bioservices to Report Financial Results For Quarter and Fiscal Year Ended April 30, 2021 After Market Close on June 29, 2021GlobeNewsWire • 06/22/21
Avid Bioservices (CDMO) Q4 Earnings Preview: What's in the Cards?Zacks Investment Research • 06/22/21
Avid Bioservices (CDMO) Stock Jumps 7.2%: Will It Continue to Soar?Zacks Investment Research • 06/04/21